Polymorphic form of a [1,2,4]triazole[4,3-A] pyridine derivative inflammatory diseases
    1.
    发明授权
    Polymorphic form of a [1,2,4]triazole[4,3-A] pyridine derivative inflammatory diseases 有权
    [1,2,4]三唑[4,3-A]吡啶衍生物炎症性疾病的多形态

    公开(公告)号:US08222273B2

    公开(公告)日:2012-07-17

    申请号:US12865889

    申请日:2009-01-28

    IPC分类号: A61K31/437 C07D471/07

    CPC分类号: C07D471/04

    摘要: The present invention relates to a polymorphic form B of Λ/-[3-tert-butyl-1-(3-chloro-4-hydroxyphenyl)-1H-pyrazol-5-yl]-N-{2-[(3-{2-[(2-hydroxyethyl)sulfanyl]phenyl}[1,2,4]triazolo[4,3-a]pyridin-6-yl)sulfanyl]benzyl}urea (I) as de-fined herein. This polymorph is useful in the treatment of various conditions, particularly in the treatment of inflammatory conditions such as chronic obstructive pulmonary disease.

    摘要翻译: 本发明涉及Λ/ - [3-叔丁基-1-(3-氯-4-羟基苯基)-1H-吡唑-5-基] -N- {2 - [(3- 苯基} [1,2,4]三唑并[4,3-a]吡啶-6-基)硫烷基]苄基}脲(I)。 该多晶型物可用于治疗各种病症,特别是治疗炎症性疾病如慢性阻塞性肺疾病。